Abstract 4692: BGB-283, a novel RAF kinase and EGFR dual inhibitor, displays potent antitumor activity in B-RAF mutated colorectal cancers

MLA

Lai Wang, et al. “Abstract 4692: BGB-283, a Novel RAF Kinase and EGFR Dual Inhibitor, Displays Potent Antitumor Activity in B-RAF Mutated Colorectal Cancers.” Cancer Research, vol. 75, Aug. 2015, p. 4692. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........0b3dfa344e355c2bab6cc0bc5fa8a7ff&authtype=sso&custid=ns315887.

APA

Lai Wang, Lusong Luo, Shuangxi Li, Min Wei, Wenfeng Gong, Yuan Zhao, Yong Liu, Yunguang Du, Rong Du, Yi Zhang, Changyou Zhou, Rui Hao, Lianhai Zhang, Xiaoxia Hu, Yajuan Gao, Yingcai Feng, David Sutton, Xi Yuan, Jing Wei, … Zhiyu Tang. (2015). Abstract 4692: BGB-283, a novel RAF kinase and EGFR dual inhibitor, displays potent antitumor activity in B-RAF mutated colorectal cancers. Cancer Research, 75, 4692.

Chicago

Lai Wang, Lusong Luo, Shuangxi Li, Min Wei, Wenfeng Gong, Yuan Zhao, Yong Liu, et al. 2015. “Abstract 4692: BGB-283, a Novel RAF Kinase and EGFR Dual Inhibitor, Displays Potent Antitumor Activity in B-RAF Mutated Colorectal Cancers.” Cancer Research 75 (August): 4692. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........0b3dfa344e355c2bab6cc0bc5fa8a7ff&authtype=sso&custid=ns315887.